Table 5 Survival analysis of patients depending on the underlying disease and thromboembolic events
Variable | Group | No of patients | No of deaths | Median survival (95% CI) | 3-year survival (95% CI) | 5-year survival (95% CI) | p-value log-rank test |
|---|---|---|---|---|---|---|---|
Disease | cHP | 152 | 38 | 121.5 (110.1–NA) | 96.16 (92.91–99.54) | 90.05 (84.16–96.35) | < 0.001 |
IPF | 259 | 116 | 79.9 (68.7–105.8) | 81.36 (76.33–86.73) | 60.78 (53.94–68.47) | ||
VTE | No | 394 | 146 | 105.8 (90.6–117.9) | 86.61 (82.97–90.41) | 71.86 (66.56–77.57) | 0.593 |
Yes | 17 | 8 | 60.7 (46.5–NA) | 87.84 (73.37–100.00) | 55.29 (33.46–91.34) |